Drexel University’s LeBow College of Business today announced the establishment of the Manuel Stamatakis Center for ...

Scheduled for Second Half of January -PURCHASE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing ...

Preclinical in vivo data demonstrate hyper-precise mechanism directly targets the disease-causing mRNA repeats leading to correction of splicing defects and reversal of myotonia Oral administration of ...

A clear breakdown of how the UK Autumn Budget's tax changes—from frozen thresholds to new caps and allowances—will reshape ...

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S.

Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, ...

The rise of AI in society overall is seeping into the senior living industry, as companies and communities adopt various programs and processes to improve efficiencies and resident satisfaction.

CKM syndrome, which links heart disease, kidney disease, diabetes, and obesity, is a fairly new concept. As a result, ...

Biotech veteran with over 25 years of business development, strategy and operational experience joins March Bio’s management team ...

US Attorney Jeanine Pirro's office in Washington, DC, charged him with murder and two counts of assault with intent to kill while armed.

For a lot of guys who’ve been chasing good bourbon for the last twenty years, the words “six-year-old single barrel at cask ...

The Haven Strategy Is Intact Switzerland has long sold something money cannot easily buy elsewhere: institutional continuity.